Stem-cell transplantation for multiple myeloma in the era of novel drugs.
about
Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexityA mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple myelomaA staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma.International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.Bortezomib in the front-line treatment of multiple myeloma.In pursuit of the allo-immune response in multiple myeloma: where do we go from here?Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma.Environmental-mediated drug resistance: a target for multiple myeloma therapy.Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program.Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma.Association of response endpoints with survival outcomes in multiple myeloma.Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean mulSelection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF.Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy.A case of multiple myeloma possibly cured by autologous blood stem cell transplantation.
P2860
Q26771331-FB23C80F-F1D5-48B8-9DCA-78C461AA03B7Q30498959-6E4738FA-B805-440C-960B-4CBA8C65F8F1Q33412636-67A0BA27-894B-480C-82AD-41A8197A3216Q34077188-306086B1-EAF7-41FA-89F3-81B7DE6B5015Q35802414-92DF5823-F021-4E2E-BA37-FBAA253FBC46Q36960349-D09A506C-3EBC-46B4-A062-F8C7BD486A39Q37202761-59B32D0B-8AA9-4955-8248-CD8254662C96Q37349835-4DCEB440-CA31-43EE-976C-1FA0A8AB5D8EQ37370051-A83A4BA2-94A5-4340-A02D-DB49C2C3BF69Q37671504-DD72EFB4-9602-467D-B2DF-578C318C5489Q37810085-7A8A6F3D-DD51-421C-ABA2-0CBCEACD4C5AQ38025703-F6EDCBEC-7583-47F4-B357-07E1D9ADFC8EQ38095526-6707106F-EA20-47B6-B98D-C8EEB1677EA2Q38122624-083318BC-36A2-446F-836D-546387E5B023Q38418369-F077E0A6-CDE5-4731-A24F-0589821986C7Q41274044-3EB4CC7D-B723-4C8C-A6ED-FE3E3B1469E1Q46416585-F6D6B959-9488-4488-9C20-D4A952BBA5BDQ53468782-7527FCBC-4495-4241-8DEB-28E2F91381F7
P2860
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
@en
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
@nl
type
label
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
@en
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
@nl
prefLabel
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
@en
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
@nl
P356
P1476
Stem-cell transplantation for multiple myeloma in the era of novel drugs.
@en
P2093
William Bensinger
P304
P356
10.1200/JCO.2007.11.6863
P407
P577
2007-12-03T00:00:00Z